First Time Loading...
A

Anhui Sunhere Pharmaceutical Excipients Co Ltd
SZSE:300452

Watchlist Manager
Anhui Sunhere Pharmaceutical Excipients Co Ltd
SZSE:300452
Watchlist
Price: 13.14 CNY -2.95% Market Closed
Updated: May 16, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Anhui Sunhere Pharmaceutical Excipients Co Ltd

Wall Street analysts forecast Anhui Sunhere Pharmaceutical Excipients Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Anhui Sunhere Pharmaceutical Excipients Co Ltd is 18.36 CNY with a low forecast of 18.18 CNY and a high forecast of 18.9 CNY.

Lowest Forecast
Wall Street Target
18.18 CNY
38% Upside
Average Forecast
Wall Street Target
18.36 CNY
40% Upside
Highest Forecast
Wall Street Target
18.9 CNY
44% Upside
Lowest
Price Target
18.18 CNY
38% Upside
Average
Price Target
18.36 CNY
40% Upside
Highest
Price Target
18.9 CNY
44% Upside
Anhui Sunhere Pharmaceutical Excipients Co Ltd Competitors:
Price Targets
603139
Shaanxi Kanghui Pharmaceutical Co Ltd
40% Upside
G
002424
Guizhou Bailing Group Pharmaceutical Co Ltd
369% Upside
4548
Seikagaku Corp
151% Upside
N
600812
North China Pharmaceutical Co Ltd
139% Upside
603139
Shaanxi Kanghui Pharmaceutical Co Ltd
40% Upside
G
002424
Guizhou Bailing Group Pharmaceutical Co Ltd
369% Upside
4548
Seikagaku Corp
151% Upside
N
600812
North China Pharmaceutical Co Ltd
139% Upside
V
VRNO
Verano Holdings Corp
149% Upside
002422
Sichuan Kelun Pharmaceutical Co Ltd
23% Upside
A
000739
Apeloa Pharmaceutical Co Ltd
34% Upside
NECLIFE
Nectar Lifesciences Ltd
28% Upside

Revenue
Forecast

Revenue Estimate
Anhui Sunhere Pharmaceutical Excipients Co Ltd

For the last 8 years the compound annual growth rate for Anhui Sunhere Pharmaceutical Excipients Co Ltd's revenue is 16%. The projected CAGR for the next 2 years is 19%.

16%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Anhui Sunhere Pharmaceutical Excipients Co Ltd

For the last 8 years the compound annual growth rate for Anhui Sunhere Pharmaceutical Excipients Co Ltd's operating income is 18%. The projected CAGR for the next 4 years is -12%.

18%
Past Growth
-12%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Anhui Sunhere Pharmaceutical Excipients Co Ltd

For the last 8 years the compound annual growth rate for Anhui Sunhere Pharmaceutical Excipients Co Ltd's net income is 18%. The projected CAGR for the next 2 years is 20%.

18%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Anhui Sunhere Pharmaceutical Excipients Co Ltd's stock price target?
Price Target
18.36 CNY

According to Wall Street analysts, the average 1-year price target for Anhui Sunhere Pharmaceutical Excipients Co Ltd is 18.36 CNY with a low forecast of 18.18 CNY and a high forecast of 18.9 CNY.

What is Anhui Sunhere Pharmaceutical Excipients Co Ltd's Revenue forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Anhui Sunhere Pharmaceutical Excipients Co Ltd's revenue is 16%. The projected CAGR for the next 2 years is 19%.

What is Anhui Sunhere Pharmaceutical Excipients Co Ltd's Operating Income forecast?
Projected CAGR
-12%

For the last 8 years the compound annual growth rate for Anhui Sunhere Pharmaceutical Excipients Co Ltd's operating income is 18%. The projected CAGR for the next 4 years is -12%.

What is Anhui Sunhere Pharmaceutical Excipients Co Ltd's Net Income forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for Anhui Sunhere Pharmaceutical Excipients Co Ltd's net income is 18%. The projected CAGR for the next 2 years is 20%.

ALPHA SPREAD
Join more than 137,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.